PD-L1 blockade by atezolizumab downregulates signaling pathways associated with tumor growth, metastasis, and hypoxia in human triple negative breast cancer
Reem Saleh, Rowaida Z. Taha, Varun Sasidharan Nair, Nehad M. Alajez, Eyad Elkord*
Research output: Contribution to journal › Article › peer-review
53Citations
(Scopus)
Fingerprint
Dive into the research topics of 'PD-L1 blockade by atezolizumab downregulates signaling pathways associated with tumor growth, metastasis, and hypoxia in human triple negative breast cancer'. Together they form a unique fingerprint.